Christina H. Ruhlmann, Principal Investigator at Danish Metastatic Melanoma Database (DAMMED) and Associate Professor at OUH Odense University Hospital, shared a post on LinkedIn:
“The survey on understanding the gaps in IO-toxicity management across European countries was presented today by Maggie O’Connor. I missed the prime time at the poster session, but not the important key takeaways:
- Gaps in the knowledge on the usage of 2nd line immunosuppressants
- A need for collaborative networks between oncologists and organ specialists for proper IO toxicity management
A huge thanks to the IO-tox ‘working group’ emerging from the ESMO – European Society for Medical Oncology Supportive care faculty and the Practicing Oncology work group.”
Follow the latest ESMO 2025 news on OncoDaily.
